###begin article-title 0
Methyltransferase Set7/9 Maintains Transcription and Euchromatin Structure at Islet-Enriched Genes
###end article-title 0
###begin p 1
###xml 46 64 46 64 <email xmlns:xlink="http://www.w3.org/1999/xlink">rmirmira@iupui.edu</email>
Corresponding author: Raghavendra G. Mirmira, rmirmira@iupui.edu
###end p 1
###begin p 2
Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See  for details.
###end p 2
###begin p 3
###xml 0 10 0 10 <bold xmlns:xlink="http://www.w3.org/1999/xlink">OBJECTIVE&#8212;</bold>
OBJECTIVE-The activation of beta-cell genes, particularly of those encoding preproinsulin, requires an appropriate euchromatin (or "open") DNA template characterized by hypermethylation of Lys4 of histone H3. We hypothesized that this modification is maintained in islet beta-cells by the action of the histone methyltransferase Set7/9.
###end p 3
###begin p 4
###xml 0 28 0 28 <bold xmlns:xlink="http://www.w3.org/1999/xlink">RESEARCH DESIGN AND METHODS&#8212;</bold>
###xml 199 204 <span type="species:ncbi:10090">mouse</span>
RESEARCH DESIGN AND METHODS-To identify the role of Set7/9, we characterized its expression pattern and gene regulation and studied its function using RNA interference in both cell lines and primary mouse islets.
###end p 4
###begin p 5
###xml 0 8 0 8 <bold xmlns:xlink="http://www.w3.org/1999/xlink">RESULTS&#8212;</bold>
###xml 643 649 633 639 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ins1/2</italic>
###xml 651 656 641 646 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Glut2</italic>
###xml 662 666 652 656 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MafA</italic>
###xml 803 809 793 799 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ins1/2</italic>
###xml 814 819 804 809 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Glut2</italic>
###xml 924 926 914 916 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 471 476 <span type="species:ncbi:10090">mouse</span>
RESULTS-Within the pancreas, Set7/9 protein shows striking specificity for islet cells, including alpha- and beta-cells, as well as occasional cells within ducts. Consistent with these findings, the Set7/9 gene promoter contained an islet-specific enhancer located between -5,768 and -6,030 base pairs (relative to the transcriptional start site) that exhibited Pdx1-responsive activation in beta-cells. To study Set7/9 function, we depleted insulinoma cells and primary mouse islets of Set7/9 protein using siRNA. Following siRNA treatment, we observed striking repression of genes involved in glucose-stimulated insulin secretion, including Ins1/2, Glut2, and MafA. These changes in transcription were accompanied by loss of dimethylated H3 Lys4 and RNA polymerase II recruitment, particularly at the Ins1/2 and Glut2 genes. Consistent with these data, depletion of Set7/9 in islets led to defects in glucose-stimulated Ca2+ mobilization and insulin secretion.
###end p 5
###begin p 6
###xml 0 12 0 12 <bold xmlns:xlink="http://www.w3.org/1999/xlink">CONCLUSIONS&#8212;</bold>
CONCLUSIONS-We conclude that Set7/9 is required for normal beta-cell function, likely through the maintenance of euchromatin structure at genes necessary for glucose-stimulated insulin secretion.
###end p 6
###begin p 7
Published ahead of print at  on 4 November 2008.
###end p 7
###begin p 8
The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
###end p 8
###begin p 9
###xml 32 34 32 34 <related-article xmlns:xlink="http://www.w3.org/1999/xlink" related-article-type="commentary" vol="58" page="28" id="N0x3a74720N0x401cd80" xlink:href="19114729" ext-link-type="pubmed">28</related-article>
See accompanying commentary, p. 28.
###end p 9
###begin p 10
###xml 156 157 153 154 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r1">1</xref>
###xml 668 669 653 654 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r2">2</xref>
###xml 670 671 655 656 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r4">4</xref>
###xml 1321 1322 1297 1298 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r5">5</xref>
###xml 1323 1324 1299 1300 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r7">7</xref>
###xml 1458 1459 1434 1435 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
It is becoming increasingly clear that the pathogenesis of type 1 and type 2 diabetes involves progressive dysfunction at the level of the islet beta-cell (1). Thus, the most effective therapeutic approaches to diabetes should include efforts to address beta-cell dysfunction, and further research into the mechanisms underlying beta-cell gene transcription will be paramount in these efforts. In recent years, a model has been emerging that emphasizes the role of beta-cell-specific transcription factors such as Pdx1, Nkx6.1, NeuroD1, and Maf factors in the expression and regulation of genes crucial to the development and function of beta-cells (recent reviews in 2-4). However, transduction of a variety of non-beta-cell types with these and other transcription factors has yielded limited success in activating beta-cell genes and suggests that this model of beta-cell gene activation requires further refinement. In this regard, chromatin structure is becoming recognized as a crucial factor in modulating eukaryotic gene expression. Covalent modifications of the histone proteins H2A, H2B, H3, and H4 that make up the fundamental unit of chromatin have been shown to directly or indirectly lead to the formation of euchromatin ("open," or active, chromatin) or heterochromatin ("closed," or inactive, chromatin) (5-7). These modifications include methylation, acetylation, phosphorylation, and ubiquitination of specific amino acid residues in the NH2-terminal histone tails. The roles of chromatin and histone modifications in beta-cell gene transcription have received attention only in recent years.
###end p 10
###begin p 11
###xml 383 384 377 378 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r8">8</xref>
###xml 569 570 563 564 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r9">9</xref>
###xml 726 732 720 726 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ins1/2</italic>
###xml 905 907 896 898 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r10">10</xref>
###xml 908 910 899 901 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r11">11</xref>
###xml 1106 1112 1097 1103 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ins1/2</italic>
###xml 1119 1121 1110 1112 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r10">10</xref>
###xml 1237 1239 1228 1230 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r12">12</xref>
###xml 1240 1242 1231 1233 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r13">13</xref>
###xml 1406 1408 1397 1399 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r14">14</xref>
###xml 1409 1411 1400 1402 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r19">19</xref>
###xml 1682 1684 1673 1675 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r11">11</xref>
Our laboratory and others have been particularly interested in the role of methylation of Lys4 of H3 in the activation of beta-cell genes. For example, recent studies have demonstrated that H3-Lys4 methylation at the control region of the genes encoding cell cycle inhibitors p27Kip1 and p18Inc4c is crucial in their activation and subsequent suppression of beta-cell tumorigenesis (8). Maintenance of this methylation state appears to involve a complex containing the protein menin and members of the SET methyltransferase family, the mixed lineage leukemia proteins (9). Similarly, our laboratory has demonstrated that mono- and dimethylation of H3 Lys4 is enriched in the control region of the gene encoding preproinsulin (Ins1/2) and that the maintenance of dimethylated H3 Lys4 by a transcriptional protein complex involving Pdx1 is crucial to the ongoing activation of this gene in beta-cell lines (10,11). Because Pdx1 contains no methyltransferase activity, we proposed that another member of the SET protein family, Set7/9, may be recruited to a complex with Pdx1 to mediate H3 methylation at the Ins1/2 gene (10). Set7/9 is a 366 amino acid enzyme containing a COOH-terminal SET domain that harbors methyltransferase activity (12,13). This methyltransferase activity is specific not only for H3 Lys4 but also for particular Lys residues in proteins such as p53, TAF10, and the estrogen receptor (14-19). However, consistent with a direct role in gene transcription in the islet, our prior studies using chromatin-reconstituted reporters in vitro showed that the interaction of Pdx1 with Set7/9 leads to synergistic gene activation in a methyltransferase-dependent manner (11). These data have led us to hypothesize that Set7/9 may represent a novel chromatin-modifying protein that functions in part through its recruitment to target genes by cell-specific transcription factors such as Pdx1. In this study, we show that Set7/9 is strongly enriched in islets relative to other pancreatic cell types and that it is important in the maintenance of transcription and chromatin structure at genes necessary for glucose-stimulated insulin secretion in primary islets. Taken together, our data identify Set7/9 as a novel enzymatic cofactor necessary for maintenance of islet gene transcription.
###end p 11
###begin title 12
RESEARCH DESIGN AND METHODS
###end title 12
###begin title 13
Antibodies and cells.
###end title 13
###begin p 14
###xml 383 385 376 378 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r20">20</xref>
###xml 386 388 379 381 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r21">21</xref>
###xml 509 511 502 504 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r22">22</xref>
###xml 426 430 <span type="species:ncbi:10090">mice</span>
Polyclonal antibody against monomethyl-H3 Lys4 was from Abcam, and antibodies against dimethylated H3 Lys4, Pdx1, and Set7/9 were from Millipore; anti-RNA polymerase II COOH-terminal domain was from Covance; anti-actin, anti-glucagon, and anti-insulin were from Santa Cruz Biotechnology. betaTC3 cells, INS-1 (832/13), alphaTC1.6, and NIH3T3 were maintained as previously described (20,21). Islets were isolated from C57BL/6J mice following collagenase digestion of pancreatic tissue as previously described (22). Techniques and protocols were approved by the Indiana University Institutional Animal Care and Use Committee.
###end p 14
###begin title 15
Real-time RT-PCR.
###end title 15
###begin p 16
###xml 155 159 155 159 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Actb</italic>
###xml 264 266 264 266 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r23">23</xref>
###xml 281 363 281 363 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Setd7, Slc2a2, Gck, Nkx6&#8211;1, NeuroD1, Foxo1, Pax6, Iapp, Mafa, Ipf1, Kcnj11, Abcc8,</italic>
###xml 368 373 368 373 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Foxa2</italic>
###xml 735 739 735 739 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Actb</italic>
Real time RT-PCR was performed using forward and reverse primers to amplify insulin premRNA (5'-GGGGAGCGTGGCTTCTTCTA-3' and 5' GGGGACAGAATTCAGTGGCA-3') or Actb (5'-AGGTCATCACTATTGGCAACGA-3' and 5'-CACTTCATGATGGAATTGAATGTAGTT-3') as previously described in detail (23). Primers for Setd7, Slc2a2, Gck, Nkx6-1, NeuroD1, Foxo1, Pax6, Iapp, Mafa, Ipf1, Kcnj11, Abcc8, and Foxa2 were obtained from Qiagen (Quantitech primer kit catalog nos. QT00139727, QT00103537, QT00140007, QT00143318, QT00251265, QT00116186, QT01052786, QT00101052, QT01037638, QT00102235, QT00305319, QT01042300, and QT00242809, respectively). PCR products were subcloned and sequenced to verify amplification of the correct gene product. All values are normalized to Actb mRNA levels.
###end p 16
###begin title 17
Immunoblot Assays.
###end title 17
###begin p 18
###xml 80 81 80 81 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6</sup>
Whole-cell extracts were prepared from homogenized tissues, 50 islets, or 1 x 106 betaTC3 cells by lysis in a buffer containing sodium dodecyl sulfate, and 5 mug extract was resolved by electrophoresis on a 12% SDS-polyacrylamide gel followed by immunoblot with anti-Set7/9 or anti-actin antisera. Immunoblots were visualized using the ECL-Plus system (Amersham).
###end p 18
###begin title 19
Chromatin immunoprecipitation assays.
###end title 19
###begin p 20
###xml 84 86 84 86 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r20">20</xref>
###xml 100 101 100 101 <sup xmlns:xlink="http://www.w3.org/1999/xlink">7</sup>
###xml 660 666 657 663 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ins1/2</italic>
###xml 759 765 756 762 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ins1/2</italic>
###xml 861 867 858 864 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Slc2a2</italic>
###xml 967 971 964 968 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pdx1</italic>
###xml 1071 1076 1068 1073 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Setd7</italic>
###xml 123 128 <span type="species:ncbi:10090">mouse</span>
Chromatin immunoprecipitation (ChIP) assays were performed as previously described (20). Briefly, 107 betaTC3 cells or 300 mouse islets were fixed in 1% formaldehyde to cross-link proteins to DNA, and cells were lysed and chromatin sheared to 400-600 base pairs (bp) by sonication. Antibodies were used to subsequently immunoprecipitate the protein of interest and then recovery of coimmunoprecipitated DNA fragments was assessed using SYBR green-based quantitative real-time PCR. Data are expressed as the percent recovery of coimmunoprecipitated DNA relative to input DNA (before immunoprecipitation). Primers used for amplification were as follows: for the Ins1/2 promoter, 5'-TACCTTGCTGCCTGAGTTCTGC-3' forward and 5'-GCATTTTCCACATCATTCCCC-3' reverse; the Ins1/2 coding region, 5'-TGGCTTCTTCTACACACCCAAG-3' forward and 5'-ACAATGCCACGCTTCTGCC-3' reverse; the Slc2a2 promoter, 5'-ATCTGGCTCCGCACTCTCATCTTG-3' forward and 5'- CCCTGTGACTTTTCTGTGTCTTAGG-3' reverse; the Pdx1 promoter, 5'-AGCCTGGACTACATCTTGAGTTGC-3' forward and 5'-TTACAAAACCGCTCCCAATGAG-3' reverse; and the Setd7 promoter, 5'- TCCTGTTGCCATCATCAAAA-3' forward and 5'-ACATGAAGGCACCACATGAA-3' reverse.
###end p 20
###begin title 21
Immunohistochemistry.
###end title 21
###begin p 22
###xml 533 535 532 534 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r11">11</xref>
###xml 0 5 <span type="species:ncbi:10090">Mouse</span>
###xml 127 132 <span type="species:ncbi:9606">Human</span>
###xml 198 203 <span type="species:ncbi:9606">Human</span>
###xml 295 300 <span type="species:ncbi:10090">mouse</span>
###xml 588 592 <span type="species:ncbi:9925">goat</span>
###xml 598 604 <span type="species:ncbi:9986">rabbit</span>
###xml 639 645 <span type="species:ncbi:9793">donkey</span>
###xml 651 656 <span type="species:ncbi:10090">mouse</span>
Mouse pancreata were fixed by cardiac perfusion with 4% paraformaldehyde, paraffin embedded, and sectioned at 5-mum intervals. Human pancreatic samples were obtained from the University of Virginia Human Islet Transplant Program, fixed for 2 h in 4% paraformaldehyde, and processed similarly to mouse pancreata. Immunohistochemical analysis of insulin (anti-insulin, 1:500 dilution), Pdx1 (anti-Pdx1, 1:2,000 dilution), glucagon (anti-glucagon, 1:500 dilution), and Set7/9 (anti-Set7/9, 1:50), was performed as previously described (11). For immunofluorescence, secondary antibodies were goat anti-rabbit-conjugated to Alexa Fluor 555 and donkey anti-mouse-conjugated to Alexa Fluor 488 (Molecular Probes). Images were acquired using a Zeiss Z1 microscope equipped with Apotome optical sectioning hardware.
###end p 22
###begin title 23
Transfection of cell lines with siRNA.
###end title 23
###begin p 24
###xml 112 113 112 113 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6</sup>
###xml 182 183 179 180 <sc xmlns:xlink="http://www.w3.org/1999/xlink">d</sc>
###xml 122 127 <span type="species:ncbi:10090">mouse</span>
siRNAs against Set7/9 or a scrambled control were mixed with Reagent V (Amaxa, Inc.) and transfected into 3 x 106 betaTC3 mouse insulinoma cells using an Amaxa Nucleofector (program d-23) according to the manufacturer's protocol. Cells were then plated in a six-well dish containing culture medium for 72 h and then harvested for protein, total RNA, or ChIP analysis. siRNA sequences used were as follows: siSet97, 5'-GGUUUAUGUUGCCGACUCTT-3'; siSet98, 5'-GGUAGCAGUUGGACCUAAUTT-3'; and a control siRNA (siControl), 5'-AAAGUCGACCUUCAGUAAGUU-3'.
###end p 24
###begin title 25
In vivo delivery of siRNA.
###end title 25
###begin p 26
###xml 348 350 348 350 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 104 108 <span type="species:ncbi:10090">mice</span>
###xml 156 161 <span type="species:ncbi:10090">mouse</span>
Stabilized siRNAs were obtained from Dharmacon and diluted in 0.9% saline. Eight-week-old male C57BL/6J mice were injected intraperitoneally with 1.6 mg/kg mouse wt siRNA daily for 4 days. Islets were then harvested, handpicked and allowed to recover overnight and then subjected to glucose-stimulated insulin secretion (GSIS)/glucose-stimulated Ca2+ mobilization (GSCa) studies (see below), protein isolation, or RNA isolation. siRNA sequences used were as follows: siSet1, 5'-CGGACAGAUUUGAGGGCAAUU-3'; siSet2, 5'-GGGUUUAUGUUGCCGACUCUU-3; and siControl, 5'-AAAGUCGACCUUCAGUAAGUU-3'.
###end p 26
###begin title 27
GSIS and GSCa studies.
###end title 27
###begin p 28
###xml 380 382 374 376 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 427 429 421 423 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r24">24</xref>
###xml 330 335 <span type="species:ncbi:10090">mouse</span>
For GSIS studies, 50 islets per condition were incubated in Krebs-Ringer HEPES buffered solution for 1 h at 37degreesC and then placed in Krebs-Ringer HEPES buffered solution containing 3 or 11 mmol/l glucose for 1 h. Insulin released into the medium was assayed using a two-site immunospecific ELISA (Alpco Diagnostics). GSCa in mouse islets was measured using the ratiometric Ca2+ indicator Fura-2AM as described previously (24). GSCa was defined as the difference between ratio measurements (340/380 nm fluorescence) in 11 mmol/l vs. 3 mmol/l glucose. Data were analyzed with IP Lab software, version 4.0 (Scanalytics).
###end p 28
###begin title 29
Cloning of the Setd7 promoter.
###end title 29
###begin p 30
###xml 56 61 44 49 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Setd7</italic>
###xml 144 149 132 137 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Setd7</italic>
###xml 245 247 233 235 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r25">25</xref>
###xml 269 274 257 262 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Setd7</italic>
A genomic clone containing approximately8,000 bp of the Setd7 gene was used as a template in PCR reactions to generate various fragments of the Setd7 gene, which were then subcloned upstream of the luciferase coding sequence in plasmid pFoxLuc (25). Mutagenesis of the Setd7 gene was performed using the QuickChange Site-Directed Mutagenesis Kit (Stratagene) according to the manufacturer's instructions. All sequences were confirmed by automated DNA sequencing.
###end p 30
###begin title 31
Transfections and reporter assays.
###end title 31
###begin p 32
###xml 2 3 2 3 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6</sup>
###xml 44 45 37 38 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5</sup>
106 betaTC3/alphaTC1.6/INS-1 cells or 5 x 105 NIH3T3 cells were seeded in six-well plates 24 h before transfection. Plasmid (2 mug) diluted into 0.1 ml PBS was mixed with 6 mul of Metafectene Pro (Biotex) and incubated at room temperature for 15 min. The transfection mixture was added to each well of a six-well plate along with 2 ml medium without antibiotics. At 6 h after transfection, the medium was replaced with fresh medium containing antibiotics. At 48 h after transfection, cells were harvested and a luciferase assay was performed utilizing a commercially available luminometric kit (Promega). Luciferase activity was normalized to protein concentration as measured using the Bio-Rad Protein Assay reagent (Bio-Rad) according to manufacturer's instructions.
###end p 32
###begin title 33
RESULTS
###end title 33
###begin title 34
Set7/9 mRNA and protein are enriched in pancreatic islets.
###end title 34
###begin p 35
###xml 187 188 187 188 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 181 188 181 188 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f1" ref-type="fig">Fig. 1<italic>A</italic></xref>
###xml 421 422 421 422 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 415 422 415 422 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f1" ref-type="fig">Fig. 1<italic>B</italic></xref>
###xml 748 749 748 749 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 742 749 742 749 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f1" ref-type="fig">Fig. 1<italic>B</italic></xref>
###xml 927 928 927 928 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 919 928 919 928 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f1" ref-type="fig">Figure 1<italic>C</italic></xref>
###xml 933 934 933 934 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 1187 1190 1184 1187 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E&#8211;G</italic>
###xml 1181 1190 1178 1187 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f1" ref-type="fig">Fig. 1<italic>E&#8211;G</italic></xref>
###xml 1276 1277 1269 1270 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H</italic>
###xml 1278 1279 1271 1272 <italic xmlns:xlink="http://www.w3.org/1999/xlink">J</italic>
###xml 1270 1279 1263 1272 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f1" ref-type="fig">Fig. 1<italic>H</italic>&#8211;<italic>J</italic></xref>
###xml 1347 1350 1340 1343 <italic xmlns:xlink="http://www.w3.org/1999/xlink">K&#8211;M</italic>
###xml 1341 1350 1334 1343 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f1" ref-type="fig">Fig. 1<italic>K&#8211;M</italic></xref>
###xml 55 59 <span type="species:ncbi:10090">mice</span>
###xml 902 906 <span type="species:ncbi:10090">mice</span>
###xml 911 917 <span type="species:ncbi:9606">humans</span>
###xml 989 994 <span type="species:ncbi:10090">mouse</span>
###xml 1353 1358 <span type="species:ncbi:9606">Human</span>
###xml 1442 1447 <span type="species:ncbi:10090">mouse</span>
To evaluate the tissue distribution of Set7/9 in adult mice, Set7/9 mRNA and protein were assayed in different tissues by real-time RT-PCR and immunoblot, respectively. As shown in Fig. 1A, mRNA levels demonstrate a pattern of tissue-specific enhancement, with the highest relative levels seen in muscle, brain, heart, and pancreas. Interestingly, Set7/9 protein levels do not completely mirror Set7/9 mRNA levels (Fig. 1B), as no protein was detectable in either heart or total pancreas and very little was detectable in muscle. These data suggest the potential for posttranscriptional regulation of Set7/9 expression. However, within the pancreas, there was clear enrichment of Set7/9 protein within islets as determined by immunoblotting (Fig. 1B). To directly visualize the distribution of Set7/9 among pancreatic cell types, we next performed immunohistochemistry of pancreatic sections from both mice and humans. Figure 1C and D shows that Set7/9 is strikingly enriched in islets of mouse pancreas, with a predominantly nuclear pattern in most cells of the central islet. Coimmunofluorescence revealed that Set7/9 exhibited a nuclear pattern in insulin-producing beta-cells (Fig. 1E-G) and both a nuclear and cytoplasmic pattern in glucagon-producing alpha-cells (Fig. 1H-J). All Pdx1-positive cells of the islet costained for Set7/9 (Fig. 1K-M). Human pancreas sections demonstrated a Set7/9 staining pattern identical to that seen in mouse sections (supplemental Fig. S1, available in an online appendix at ).
###end p 35
###begin title 36
beta-Cell-specific transcription of the Setd7 gene.
###end title 36
###begin p 37
###xml 232 237 232 237 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Setd7</italic>
###xml 255 265 255 265 <italic xmlns:xlink="http://www.w3.org/1999/xlink">luciferase</italic>
###xml 301 303 301 303 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r25">25</xref>
###xml 506 507 492 493 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 500 507 486 493 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f2" ref-type="fig">Fig. 2<italic>A</italic></xref>
###xml 974 979 954 959 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Setd7</italic>
###xml 1493 1495 1443 1445 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r20">20</xref>
###xml 1496 1498 1446 1448 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r26">26</xref>
###xml 1569 1574 1519 1524 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Setd7</italic>
###xml 1797 1798 1744 1745 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 1791 1798 1738 1745 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f2" ref-type="fig">Fig. 2<italic>B</italic></xref>
###xml 2088 2089 2011 2012 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 2082 2089 2005 2012 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f2" ref-type="fig">Fig. 2<italic>C</italic></xref>
###xml 2094 2095 2017 2018 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 2212 2213 2132 2133 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 2206 2213 2126 2133 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f2" ref-type="fig">Fig. 2<italic>C</italic></xref>
###xml 2218 2219 2138 2139 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 2260 2265 2180 2185 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Setd7</italic>
###xml 2422 2423 2336 2337 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E</italic>
###xml 2416 2423 2330 2337 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f2" ref-type="fig">Fig. 2<italic>E</italic></xref>
###xml 2467 2472 2381 2386 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Setd7</italic>
###xml 2664 2669 2575 2580 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Setd7</italic>
###xml 952 957 <span type="species:ncbi:9606">human</span>
###xml 959 964 <span type="species:ncbi:10090">mouse</span>
###xml 970 973 <span type="species:ncbi:10116">rat</span>
The islet-specific enrichment of Set7/9 suggested the potential for regulation at the transcriptional level. To explore this possibility, we placed a range of DNA fragments from the 5' regulatory region of the gene encoding Set7/9 (Setd7) upstream of the luciferase reporter gene (in plasmid pFoxLuc [25]). These constructs were then transfected into the beta-cell-derived cell lines betaTC3 and INS-1, the alpha-cell-derived cell line alphaTC1.6, and the fibroblast-derived line NIH3T3. As shown in Fig. 2A, beta-cell lines displayed enhancement of luciferase activity with a DNA fragment containing -6,584 bp upstream of the transcriptional start site. This enhancement was significantly attenuated when a fragment containing -3,131 bp from the transcriptional start site was used, suggesting the potential for a beta-cell-specific enhancer located between -3,131 and -6,584 bp. To further explore this possibility, we next performed an alignment of human, mouse, and rat Setd7 genes to identify regions of homology that might suggest conserved beta-cell-specific enhancer regions. Although the entire region between -3,131 and -6,584 bp only exhibited approximately25% identity between these species (data not shown), we identified a region between -5,768 and -6,030 bp that exhibited approximately68% identity (supplemental Fig. S2). Within this conserved region, we identified two potential binding sites for the beta-cell-specific transcription factor Pdx1 (consensus: 5'-TAAT-3' [refs. 20,26]) (supplemental Fig. S2). To directly test whether this region of the Setd7 gene might be regulated in beta-cells, a DNA fragment containing this conserved region was placed upstream of the prolactin minimal promoter driving luciferase and used in reporter gene analysis studies. As shown in Fig. 2B, this fragment displayed relative enhancement of luciferase activity in betaTC3 and INS-1 beta-cell lines,but not in NIH3T3 cells. Upon cotransfection with a plasmid encoding Pdx1, this fragment displayed an approximately25-fold enhancement in the beta-cell lines INS-1 and betaTC3 (Fig. 2C and D). Mutation of either putative Pdx1 binding site attenuated activity of this fragment in both beta-cell lines (Fig. 2C and D). Pdx1 appears to occupy the endogenous Setd7 gene in betaTC3 cells within the region around -6,000 bp, as assessed by the ChIP assay, but does not occupy the endogenous gene encoding beta-actin (Fig. 2E). Together, these results suggest that the Setd7 gene may contain elements that enhance its expression specifically in beta-cells and that the islet transcription factor Pdx1 may be a necessary component of a transactivation complex on the Setd7 gene.
###end p 37
###begin title 38
Set7/9 is necessary for the expression of a subset of glucose-responsive genes in beta-cell lines and islets.
###end title 38
###begin p 39
###xml 343 344 334 335 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 337 344 328 335 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f3" ref-type="fig">Fig. 3<italic>A</italic></xref>
###xml 767 771 755 759 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MafA</italic>
###xml 805 811 793 799 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Slc2a2</italic>
###xml 833 839 821 827 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ins1/2</italic>
###xml 875 876 863 864 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 869 876 857 864 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f3" ref-type="fig">Fig. 3<italic>B</italic></xref>
###xml 1039 1043 1027 1031 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pdx1</italic>
###xml 1065 1066 1053 1054 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1076 1082 1064 1070 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Kcnj11</italic>
###xml 1109 1114 1097 1102 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Abcc8</italic>
###xml 1125 1131 1113 1119 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nkx6.1</italic>
###xml 1147 1154 1135 1142 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NeuroD1</italic>
###xml 1227 1228 1215 1216 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 1221 1228 1209 1216 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f3" ref-type="fig">Fig. 3<italic>B</italic></xref>
###xml 261 267 <span type="species:ncbi:10090">murine</span>
To determine the role of Set7/9 in the regulation of beta-cell-specific genes, we next depleted betaTC3 cells of Set7/9 protein and analyzed gene expression by real-time RT-PCR. To knock down protein, two different siRNAs (siSet97 and siSet98) targeted against murine Set7/9 or siControl were transfected into betaTC3 cells. As shown in Fig. 3A, >90% reductions in Set7/9 protein were seen following transfections with each siRNA compared with those seen in control transfections. Use of two different siRNAs ensured that any effects on gene transcription were unlikely a result of off-target effects of these siRNAs. A survey of islet-specific genes involved in glucose responsiveness showed that the genes encoding the beta-cell-specific transcription factor MafA (MafA), the glucose transporter Glut2 (Slc2a2), and preproinsulin (Ins1/2) were reduced significantly (Fig. 3B) in cells depleted of Set7/9. However, reduction was not seen uniformly among all genes responsible for glucose responsiveness in islets, as those encoding Pdx1 (Pdx1), the ATP-sensitive K+ channel (Kcnj11), sulfonylurea receptors (Abcc8), Nkx6.1 (Nkx6.1), and NeuroD1 (NeuroD1) appeared statistically unaffected by acute reductions in Set7/9 (Fig. 3B).
###end p 39
###begin p 40
###xml 299 301 299 301 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r27">27</xref>
###xml 489 491 489 491 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r28">28</xref>
###xml 492 494 492 494 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r29">29</xref>
###xml 736 737 736 737 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 730 737 730 737 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f4" ref-type="fig">Fig. 4<italic>A</italic></xref>
###xml 1161 1162 1161 1162 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 1155 1162 1155 1162 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f4" ref-type="fig">Fig. 4<italic>B</italic></xref>
###xml 85 90 <span type="species:ncbi:10090">mouse</span>
###xml 651 655 <span type="species:ncbi:10090">mice</span>
###xml 989 993 <span type="species:ncbi:10090">mice</span>
###xml 1057 1061 <span type="species:ncbi:10090">mice</span>
To confirm our findings in primary cells, we next performed knockdown experiments in mouse islets. However, a major challenge in RNA intereference studies in primary rodent islets is their relatively poor transfection efficiency in vitro, which typically necessitates use of viral-based approaches (27). Instead, we sought to knock down Set7/9 in islets by delivering chemically stabilized siRNAs in vivo. A similar technique has been used to target other proteins for systemic knockdown (28,29). To test the efficacy of this approach in islets, we performed four daily intraperitoneal injections of Cy3-labeled double-stranded RNA into male C57BL/6J mice and subsequently isolated islets from these animals on day 5. As shown in Fig. 4A, fluorescent microscopic images of isolated islets revealed penetration of the Cy3 label into the islets, suggesting islet entry of siRNA. Two different stabilized siRNAs targeted against Set7/9 (siSet1 and siSet2) or siControl were then delivered to mice using the same approach. Following the injections, islets from mice were then harvested and studied by immunoblot, real-time RT-PCR, GSCa, and GSIS. As shown in Fig. 4B, islet Set7/9 protein was reduced by at least 60% by treatment with either siRNA compared with control. Interestingly, similar knockdown was not observed in liver, brain, or muscle, suggesting that for the specific protocol employed, targeting of islets appeared to be most efficient.
###end p 40
###begin p 41
###xml 115 128 112 125 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MafA, Slc2a2,</italic>
###xml 133 139 130 136 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ins1/2</italic>
###xml 147 148 144 145 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 141 148 138 145 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f5" ref-type="fig">Fig. 5<italic>A</italic></xref>
###xml 392 394 389 391 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 584 586 578 580 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 613 615 607 609 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 690 692 684 686 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r30">30</xref>
###xml 713 714 707 708 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 707 714 701 708 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f5" ref-type="fig">Fig. 5<italic>B</italic></xref>
###xml 990 991 972 973 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 984 991 966 973 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f5" ref-type="fig">Fig. 5<italic>C</italic></xref>
Consistent with the data observed in betaTC3 cells, depletion of Set7/9 in primary islets resulted in decreases in MafA, Slc2a2, and Ins1/2 (Fig. 5A). Because decreases in these genes would be predicted to result in loss of glucose responsiveness in islets, we tested islet functionality by GSCa. The GSCa assay is a Fura-2AM dye-based assay that measures the intracellular mobilization of Ca2+ in response to glucose and is dependent on an intact signaling cascade that begins with the transport of glucose into the beta-cell by GLUT2 and ending in the activation of voltage-gated Ca2+ channels; intracellular Ca2+ mobilization through this cascade is closely linked to insulin secretion (30). As shown in Fig. 5B, reductions in islet Set7/9 protein using either siSet1 or siSet2 resulted in GSCa responses (from 3 to 11 mmol/l glucose) that were only approximately50% those associated with control. These islets also showed diminished GSIS upon raising glucose from 3 to 11 mmol/l (Fig. 5C). Taken together, these results suggest that Set7/9 is necessary for the transcription of a subset of islet genes that are required for the maintenance of normal islet function.
###end p 41
###begin title 42
###xml 72 78 72 78 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ins1/2</italic>
###xml 83 89 83 89 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Slc2a2</italic>
Set7/9 is necessary for the maintenance of H3-Lys4 dimethylation at the Ins1/2 and Slc2a2 genes.
###end title 42
###begin p 43
###xml 64 70 64 70 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ins1/2</italic>
###xml 95 97 92 94 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r10">10</xref>
###xml 152 158 149 155 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ins1/2</italic>
###xml 195 197 192 194 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r10">10</xref>
###xml 198 200 195 197 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r11">11</xref>
###xml 381 387 378 384 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ins1/2</italic>
###xml 519 520 516 517 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 513 520 510 517 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f6" ref-type="fig">Fig. 6<italic>A</italic></xref>
###xml 663 669 657 663 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ins1/2</italic>
###xml 906 912 900 906 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ins1/2</italic>
###xml 925 926 919 920 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 919 926 913 920 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f6" ref-type="fig">Fig. 6<italic>B</italic></xref>
In prior ChIP studies, we demonstrated that Set7/9 occupies the Ins1/2 genes in betaTC3 cells (10). This observation, coupled with the finding that the Ins1/2 gene is hypermethylated at H3 Lys4 (10,11), suggested to us that Set7/9 may be directly responsible for the maintenance of this euchromatin histone modification at this gene. We therefore wondered whether the reduction in Ins1/2 gene activity observed upon knockdown of Set7/9 in this study could be secondary to loss of H3-Lys4 methylation. As shown in Fig. 6A, depletion of Set7/9 in betaTC3 cells using either of two siRNAs (siSet97 or siSet98) led to 50-80% reductions in dimethylated H3 Lys4 in the Ins1/2 promoter region as determined by ChIP assay but did not affect dimethylated H3 Lys4 in the coding region of the gene. Importantly, we did not observe any changes to monomethylated H3 Lys4 in either the promoter or coding regions of the Ins1/2 gene (Fig. 6B), suggesting that Set7/9 is associated with a very specific dimethylation effect.
###end p 43
###begin p 44
###xml 67 73 67 73 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Slc2a2</italic>
###xml 129 133 129 133 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pdx1</italic>
###xml 207 208 207 208 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 201 208 201 208 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f6" ref-type="fig">Fig. 6<italic>C</italic></xref>
###xml 213 214 213 214 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 284 290 284 290 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Slc2a2</italic>
###xml 324 328 324 328 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pdx1</italic>
###xml 480 486 480 486 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ins1/2</italic>
###xml 491 497 491 497 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Slc2a2</italic>
###xml 559 560 559 560 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 553 560 553 560 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f7" ref-type="fig">Fig. 7<italic>A</italic></xref>
###xml 380 385 <span type="species:ncbi:10090">mouse</span>
To ascertain the specificity of Set7/9, we next examined the genes Slc2a2 (whose transcription is reduced by loss of Set7/9) and Pdx1 (whose transcription is unaffected by loss of Set7/9). As shown in Fig. 6C and D, we observed a specific loss of dimethylated H3 Lys4 at the proximal Slc2a2 promoter but not at the proximal Pdx1 promoter. Similar results were obtained in primary mouse islets depleted of Set7/9 using siSet1, although the decreases in dimethylated H3 Lys4 at the Ins1/2 and Slc2a2 genes did not quite approach statistical significance (Fig. 7A). These results are consistent with gene-specific effects of Set7/9.
###end p 44
###begin p 45
###xml 72 78 72 78 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Slc2a2</italic>
###xml 186 187 183 184 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 178 187 175 184 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f7" ref-type="fig">Figure 7<italic>B</italic></xref>
###xml 219 225 216 222 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Slc2a2</italic>
###xml 364 368 361 365 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pdx1</italic>
###xml 444 450 441 447 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Slc2a2</italic>
To determine whether Set7/9 could be modifying histones directly at the Slc2a2 gene, we next performed ChIP assays in betaTC3 cells to assess recruitment of Set7/9 to this gene. Figure 7B shows that Set7/9 occupies the Slc2a2 gene within its proximal control region (-738 to -523 bp relative to the transcriptional start site) but was not detected at the proximal Pdx1 promoter. These results suggest that the chromatin effects observed at the Slc2a2 gene are the result of Set7/9 recruitment to its promoter.
###end p 45
###begin title 46
###xml 68 74 68 74 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ins1/2</italic>
Set7/9 is necessary for the recruitment of RNA polymerase II to the Ins1/2 gene.
###end title 46
###begin p 47
###xml 62 68 62 68 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ins1/2</italic>
###xml 75 77 75 77 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r23">23</xref>
###xml 78 80 78 80 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r31">31</xref>
###xml 81 83 81 83 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r32">32</xref>
###xml 179 185 179 185 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ins1/2</italic>
###xml 298 300 298 300 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r11">11</xref>
###xml 301 303 301 303 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r23">23</xref>
###xml 355 361 355 361 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ins1/2</italic>
###xml 430 431 430 431 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 424 431 424 431 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f8" ref-type="fig">Fig. 8<italic>A</italic></xref>
###xml 527 533 524 530 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ins1/2</italic>
###xml 622 628 619 625 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ins1/2</italic>
###xml 634 640 631 637 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Slc2a2</italic>
###xml 684 685 669 670 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 678 685 663 670 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f8" ref-type="fig">Fig. 8<italic>B</italic></xref>
###xml 736 742 721 727 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ins1/2</italic>
Pdx1, like Set7/9, is required for the full activation of the Ins1/2 gene (23,31,32). This effect of Pdx1 is apparently related not to the recruitment of RNA polymerase II to the Ins1/2 gene but, rather, to defects in the conversion of RNA polymerase II from its initiation to elongation isoforms (11,23). We therefore wondered whether the maintenance of Ins1/2 transcription by Set7/9 might be related to Pdx1. As shown in Fig. 8A, knockdown of Set7/9 in betaTC3 cells using siSet97 led to no changes in Pdx1 occupancy at the Ins1/2 gene. However, we observed that RNA polymerase II recruitment to the promoter region of Ins1/2 (and Slc2a2) was diminished by approximately50% (Fig. 8B). These results suggest that Set7/9 action at the Ins1/2 gene may be distinct from that of Pdx1 and that either Set7/9 itself or its associated dimethylated H3-Lys4 modification is linked to RNA polymerase II recruitment.
###end p 47
###begin title 48
DISCUSSION
###end title 48
###begin p 49
###xml 536 538 530 532 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r12">12</xref>
###xml 539 541 533 535 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r13">13</xref>
###xml 643 645 637 639 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r18">18</xref>
###xml 654 656 648 650 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r17">17</xref>
###xml 664 666 658 660 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r14">14</xref>
###xml 667 669 661 663 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r16">16</xref>
###xml 695 697 689 691 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r19">19</xref>
###xml 719 721 713 715 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r11">11</xref>
###xml 839 841 833 835 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r11">11</xref>
The islet beta-cell derives many of its characteristics, particularly stimulus-secretion coupling, from the transcription of a unique subset of genes that is controlled by a group of cell-specific transcription factors and cofactors. In this report, we identify a new member of this cohort of islet-specific factors, Set7/9, and demonstrate its role in the maintenance of gene transcription and chromatin structure in beta-cell lines and primary islets. Set7/9 was originally identified as a histone H3-Lys4-specific methyltransferase (12,13). Subsequently, Set7/9 was shown to methylate Lys residues in a variety of proteins including TAF10 (18), TAF7 (17), p53 (14-16), the estrogen receptor (19), and possibly Pdx1 (11). To date, however, its role in the maintenance of histone H3-Lys4 methylation at islet genes has only been implied (11) and not directly studied.
###end p 49
###begin p 50
###xml 503 508 497 502 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Setd7</italic>
###xml 73 78 <span type="species:ncbi:10090">mouse</span>
###xml 244 249 <span type="species:ncbi:10090">mouse</span>
###xml 254 259 <span type="species:ncbi:9606">human</span>
We show that Set7/9 is distributed in a limited number of tissues in the mouse but includes those derived from all three major germ layers, including ectoderm (brain), mesoderm (muscle), and endoderm (pancreas). Within the pancreas of both the mouse and human, Set7/9 exhibits a striking islet-specific distribution pattern. The enrichment of Set7/9 in beta-cells may occur at the level of transcription, as our studies identified a potential conserved beta-cell-specific enhancer located in the distal Setd7 gene that is responsive to Pdx1. Its strongly nuclear pattern of distribution, particularly in beta-cells, suggested to us a role for Set7/9 in beta-cell gene regulation.
###end p 50
###begin p 51
###xml 324 330 315 321 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Slc2a2</italic>
###xml 332 336 323 327 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MafA</italic>
###xml 342 348 333 339 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ins1/2</italic>
###xml 1008 1010 999 1001 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r33">33</xref>
###xml 168 173 <span type="species:ncbi:10090">mouse</span>
To identify genes regulated by Set7/9 in beta-cells, we engaged RNA interference approaches to knock down Set7/9 in insulinoma-derived beta-cells (betaTC3) and primary mouse islets. Successful knockdown using multiple different siRNAs demonstrated reductions in key genes that mediate stimulus-secretion coupling, including Slc2a2, MafA, and Ins1/2. Consistent with these reductions, we observed impaired GSCa and GSIS in islets depleted of Set7/9. We note that our knockdown studies were of short duration by design in order to obtain information on the most immediate and potentially direct genetic targets of Set7/9. Thus, we cannot rule out the possibility that other genes may contribute to the dysfunctional islet phenotype observed or that more prolonged knockdown may not have broader effects on islet function, replication, or survival. Importantly, effects on islet survival are possible, given that recent studies suggest a role for Set7/9 in the maintenance of inflammatory genes in macrophages (33).
###end p 51
###begin p 52
###xml 162 164 162 164 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r34">34</xref>
###xml 258 260 258 260 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r35">35</xref>
###xml 1035 1037 1035 1037 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r36">36</xref>
As noted earlier, Set7/9 exhibits specific methyltransferase activity toward histone H3 Lys4. Some studies suggest that it may function as a dimethyltransferase (341), whereas others suggest that it functions exclusively as a monomethyltransferase in vitro (35). Although our data are compatible with the role of Set7/9 as a dimethyltransferase in cells, they do not rule out the possibility that it may indeed function as a monomethyltransferase. For example, it is possible that Set7/9 is very closely linked to a second methyltransferase that completes the dimethylation reaction in cells, such that transient alterations in monomethylation are not detectable in our system. Alternatively, it is possible that catalytic activities observed in vitro are modified in the cellular milieu as a result of the complexity of protein-protein interactions. In this context, recent studies of the H3-Lys9 methyltransferase G9a show that it exhibits differing stoichiometries of methylation in vivo depending on binding to accessory proteins (36).
###end p 52
###begin p 53
###xml 296 298 296 298 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r11">11</xref>
###xml 426 432 423 429 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ins1/2</italic>
###xml 715 717 712 714 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r11">11</xref>
###xml 718 720 715 717 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r23">23</xref>
###xml 987 989 984 986 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r18">18</xref>
In the absence of endogenous nuclear localization and DNA binding domains, we presume that Set7/9 must be chaperoned to both the nucleus and target genes through an interaction with transcription factors. We have previously demonstrated that Set7/9 forms an immunoprecipitable complex with Pdx1 (11). In those studies, we also showed that depletion of Pdx1 in betaTC3 cells leads to diminution of H3-Lys4 dimethylation at the Ins1/2 gene-an observation that our present studies suggest could be caused by disruption of the Pdx1-Set7/9 complex. Interestingly, however, whereas the depletion of Pdx1 led to defective conversion of RNA polymerase II to its elongation isoform (and not its recruitment to the promoter [11,23]), we observed here that depletion of Set7/9 causes impairments in RNA polymerase II recruitment to the promoter. Our findings are therefore consistent with studies suggesting that Set7/9 stabilizes the transcriptional preinitiation complex by methylation of TAF10 (18).
###end p 53
###begin p 54
###xml 160 166 154 160 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ins1/2</italic>
###xml 171 176 165 170 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Glut2</italic>
###xml 1144 1148 <span type="species:ncbi:10090">mice</span>
Taken together, our results suggest a model for Set7/9 action at target beta-cell genes. We propose that Set7/9 is recruited to specific beta-cell genes (e.g., Ins1/2 and Glut2) through interaction with factors such as Pdx1. This recruitment subsequently leads to dimethylation of H3 Lys4 within the promoter region (either directly by Set7/9 or through interaction with another methyltransferase) and recruitment of RNA polymerase II. The subsequent conversion of RNA polymerase II to its elongation isoform requires other factors that are dependent on Pdx1. The preponderance of studies in the literature suggest that dimethylation of H3 Lys4 appears to be crucial for laying a euchromatic template at target genes, thereby leaving genes poised for transcription. Although we have demonstrated an important role for Set7/9 in the transcriptional regulation of key beta-cell genes in mature cells, the role of Set7/9 in establishing transcriptional patterns during the embryonic development of beta-cells remains to be determined. In future studies, we will directly address its role in embryonic development using conditional Set7/9 knockout mice.
###end p 54
###begin title 55
Supplementary Material
###end title 55
###begin title 56
Online-Only Appendix
###end title 56
###begin p 57
This work is supported by a grant from the Juvenile Diabetes Research Foundation (to R.G.M.) and by grants R01 DK60581 (to R.G.M.) and T32 GM007055 (to T.G.D.) from the National Institutes of Health.
###end p 57
###begin p 58
No potential conflicts of interest relevant to this article were reported.
###end p 58
###begin p 59
###xml 43 45 43 45 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 100 105 <span type="species:ncbi:9606">human</span>
We thank Dr. C. Nunemaker for use of the Ca2+ imaging equipment and Dr. K. Brayman for provision of human pancreas sections.
###end p 59
###begin title 60
REFERENCES
###end title 60
###begin p 61
###xml 161 162 161 162 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 284 288 284 288 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Actb</italic>
###xml 346 347 346 347 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 436 437 436 437 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 442 443 442 443 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 641 642 641 642 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 653 654 653 654 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 682 685 682 685 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E&#8211;M</italic>
###xml 802 807 802 807 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E, H,</italic>
###xml 812 813 812 813 <italic xmlns:xlink="http://www.w3.org/1999/xlink">K</italic>
###xml 829 830 829 830 <italic xmlns:xlink="http://www.w3.org/1999/xlink">F</italic>
###xml 835 836 835 836 <italic xmlns:xlink="http://www.w3.org/1999/xlink">G</italic>
###xml 849 850 849 850 <italic xmlns:xlink="http://www.w3.org/1999/xlink">I</italic>
###xml 855 856 855 856 <italic xmlns:xlink="http://www.w3.org/1999/xlink">J</italic>
###xml 868 869 868 869 <italic xmlns:xlink="http://www.w3.org/1999/xlink">L</italic>
###xml 874 875 874 875 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M</italic>
###xml 37 42 <span type="species:ncbi:10090">Mouse</span>
###xml 97 102 <span type="species:ncbi:10090">mouse</span>
###xml 230 235 <span type="species:ncbi:10090">mouse</span>
###xml 411 416 <span type="species:ncbi:10090">mouse</span>
###xml 445 450 <span type="species:ncbi:10090">Mouse</span>
###xml 543 554 <span type="species:ncbi:3704">horseradish</span>
###xml 578 584 <span type="species:ncbi:9986">rabbit</span>
Tissue expression pattern of Set7/9. Mouse tissues were harvested for either RNA or protein, and mouse pancreatic tissue was harvested for immunohistochemistry. A: Quantitative real-time RT-PCR for the gene encoding Set7/9 in the mouse tissues indicated. Data shown are corrected for Actb mRNA levels and normalized to the levels seen in muscle. B: Immunoblot analysis of Set7/9 protein and actin proteins from mouse tissues indicated. C and D: Mouse pancreas was harvested, fixed, and stained using primary antibodies to Set7/9 and secondary horseradish peroxidase-linked anti-rabbit antibodies. Representative images of a pancreas at 10x (C) and 40x (D) magnifications are shown. E-M: Dual-immunofluorescence staining of representative islets from pancreatic sections showing localization of Set7/9 (E, H, and K) with insulin (F and G), glucagon (I and J), or Pdx1 (L and M). (Please see  for a high-quality digital representation of this figure.)
###end p 61
###begin p 62
###xml 24 29 24 29 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Setd7</italic>
###xml 36 37 36 37 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 302 303 302 303 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 337 342 337 342 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Setd7</italic>
###xml 597 598 597 598 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 603 604 603 604 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 606 611 606 611 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Setd7</italic>
###xml 799 800 796 797 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 812 813 809 810 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 1014 1015 1011 1012 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E</italic>
###xml 1103 1105 1097 1099 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ab</italic>
###xml 1136 1143 1130 1137 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pdx1 Ab</italic>
###xml 1169 1174 1163 1168 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Setd7</italic>
###xml 1178 1182 1172 1176 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Actb</italic>
###xml 1350 1355 1344 1349 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Setd7</italic>
###xml 18 23 <span type="species:ncbi:10090">mouse</span>
###xml 1088 1094 <span type="species:ncbi:9986">rabbit</span>
###xml 1302 1308 <span type="species:ncbi:9986">rabbit</span>
Regulation of the mouse Setd7 gene. A: Fragments of the Setd7 promoter in plasmid pFoxLuc1 (pFLO) were transfected into the cell lines indicated. Luciferase activity was measured 48 h after transfection, corrected for total protein, and normalized to the activity of the promoterless backbone plasmid. B: An A/T-rich DNA fragment of the Setd7 promoter (-5,768 to -6,030) was subcloned into a luciferase reporter plasmid driven by the prolactin minimal promoter (pFLprl) and transfected into the cell lines indicated. Luciferase activity was normalized to the activity of pFLprl-transfected cells. C and D: Setd7 gene fragments (wild-type and mutagenized at potential Pdx1 binding sites) were cotransfected with a cytomegalovirus promoter-driven plasmid (pBAT12) expressing Pdx1 into either betaTC3 (C) or INS-1 (D) cells. Luciferase activity was normalized to the activity of cells transfected with the backbone pBAT12 plasmid. Data in all panels represent the average of at least three independent transfections. E: Results of a ChIP assay using betaTC3 cell chromatin and either normal rabbit serum (-Ab) or primary antibody to Pdx1 (Pdx1 Ab). Recovery of either the Setd7 or Actb promoters were quantitated by real-time PCR, and data are expressed as fold recovery compared with the data for normal rabbit serum alone. The amplified region of the Setd7 gene (in bp) relative to the transcriptional start site is indicated in parentheses. Data represent the average from three independent ChIP experiments.
###end p 62
###begin p 63
###xml 197 198 191 192 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 234 235 228 229 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 329 333 323 327 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Actb</italic>
###xml 511 512 505 506 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
Set7/9 is necessary for the expression of a subset of glucose-responsive genes in betaTC3 cells. betaTC3 cells were transfected with the siRNAs indicated, and protein and total RNA were harvested. A: Immunoblots for Set7/9 and actin. B: Quantitative real-time RT-PCR for each of the genes indicated. Data shown are corrected for Actb mRNA levels and normalized to the levels seen with siControl transfections. Data represent the average of at least four independent transfections. *Values differ significantly (P < 0.05) from those of siControl transfections.
###end p 63
###begin p 64
###xml 135 162 135 162 <sc xmlns:xlink="http://www.w3.org/1999/xlink">research design and methods</sc>
###xml 164 165 164 165 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 497 498 494 495 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 20 25 <span type="species:ncbi:10090">mouse</span>
###xml 48 52 <span type="species:ncbi:10090">mice</span>
###xml 235 239 <span type="species:ncbi:10090">mice</span>
###xml 514 518 <span type="species:ncbi:10090">mice</span>
###xml 713 717 <span type="species:ncbi:10090">mice</span>
Set7/9 knockdown in mouse islets. Male C57BL/6J mice were administered intraperitoneal injections of stabilized siRNAs as described in research design and methods. A: Confocal microscopic imaging of representative islets isolated from mice injected with either unlabeled control siRNA or Cy3-labeled control siRNA. The panel shows islets imaged upon excitation at 488 nm (autofluorescence of islet beta-cells) and the same islets imaged upon excitation at 595 nm (corresponding to the Cy3 label). B: Male C57BL/6J mice were injected intraperitoneally with stabilized control siRNA or siRNAs against Set7/9 (siSet1 and siSet2). Shown are immunoblots of islet, brain, liver, and muscle extracts from siRNA-injected mice for Set7/9 and actin. (Please see  for a high-quality digital representation of this figure.)
###end p 64
###begin p 65
###xml 189 216 189 216 <sc xmlns:xlink="http://www.w3.org/1999/xlink">research design and methods</sc>
###xml 246 247 246 247 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 385 389 385 389 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Actb</italic>
###xml 567 568 567 568 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 616 617 616 617 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 622 623 622 623 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 675 676 675 676 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 687 688 687 688 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 747 748 747 748 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 875 876 875 876 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 981 982 981 982 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 995 996 995 996 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
###xml 61 65 <span type="species:ncbi:10090">mice</span>
###xml 270 274 <span type="species:ncbi:10090">mice</span>
###xml 646 650 <span type="species:ncbi:10090">mice</span>
###xml 811 815 <span type="species:ncbi:10090">mice</span>
###xml 930 934 <span type="species:ncbi:10090">mice</span>
Set7/9 is necessary for normal islet function. Male C57BL/6J mice were injected intraperitoneally with stabilized control siRNA or siRNAs against Set7/9 (siSet1 and siSet2) as described in research design and methods. Islets were then harvested. A: Islets from injected mice were subjected to quantitative real-time RT-PCR for each of the genes indicated. Data shown are corrected for Actb mRNA levels and normalized to the levels seen with siControl transfections. Data represent the average of at least four independent transfections. *Values differ significantly (P < 0.05) from those of siControl transfections. B and C: Islets from injected mice were subjected to GSCa (B) or GSIS (C) studies at the indicated glucose concentrations. Data in B represent the average of at least 10 islets pooled from three mice injected with each siRNA on a single occasion, and data in C represent the average of 50 islets from six injected mice. Statistical significance is indicated by the P value (from t test) for the comparison with siControl at 11 mmol/l glucose.
###end p 65
###begin p 66
###xml 214 216 208 210 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ab</italic>
###xml 371 377 365 371 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ins1/2</italic>
###xml 381 387 375 381 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Slc2a2</italic>
###xml 462 463 456 457 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 513 519 507 513 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ins1/2</italic>
###xml 549 550 543 544 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 602 608 596 602 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ins1/2</italic>
###xml 638 639 632 633 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 689 695 683 689 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Slc2a2</italic>
###xml 722 723 716 717 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 773 777 767 771 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pdx1</italic>
###xml 952 953 946 947 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 1187 1187 1150 1150 <inline-graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="cjs2113.jpg"/>
###xml 199 205 <span type="species:ncbi:9986">rabbit</span>
Set7/9 is necessary for the maintenance of dimethylated H3 Lys4 at specific genes in betaTC3 cells. betaTC3 cells were transfected with the siRNAs indicated and subjected to ChIP using either normal rabbit serum (-Ab) or antibodies to methylated histones. Recovery of the gene fragments was assessed by real-time PCR. Data are reported as recovery of the indicated gene (Ins1/2 or Slc2a2) following ChIP as a percent of the input levels of the gene before ChIP. A: Percent recovery of dimethylated H3 Lys4 at the Ins1/2 promoter and coding regions. B: Percent recovery of momomethylated H3 Lys4 at the Ins1/2 promoter and coding regions. C: Percent recovery of dimethylated H3 Lys4 at the Slc2a2 proximal promoter region. D: Percent recovery of dimethylated H3 Lys4 at the Pdx1 proximal promoter region. Data represent the average of at least three independent ChIP assays from at least three independent siRNA transfections. *Statistically different (P < 0.05) from data of siControl transfections. The amplified region of the genes (in bp) relative to the transcriptional start site is indicated in parentheses below each gene. blacksquare, square, filled, siControl; square, siSet97; , siSet98.
###end p 66
###begin p 67
###xml 71 77 71 77 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ins1/2</italic>
###xml 82 88 82 88 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Slc2a2</italic>
###xml 128 134 128 134 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Slc2a2</italic>
###xml 158 159 155 156 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 290 317 287 314 <sc xmlns:xlink="http://www.w3.org/1999/xlink">research design and methods</sc>
###xml 411 413 408 410 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ab</italic>
###xml 452 455 449 452 <italic xmlns:xlink="http://www.w3.org/1999/xlink">+Ab</italic>
###xml 659 660 656 657 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 736 738 730 732 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ab</italic>
###xml 768 777 762 771 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Set7/9 Ab</italic>
###xml 805 811 799 805 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Slc2a2</italic>
###xml 816 820 810 814 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pdx1</italic>
###xml 981 982 975 976 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 98 103 <span type="species:ncbi:10090">mouse</span>
###xml 174 178 <span type="species:ncbi:10090">mice</span>
###xml 396 402 <span type="species:ncbi:9986">rabbit</span>
###xml 616 620 <span type="species:ncbi:10090">mice</span>
###xml 721 727 <span type="species:ncbi:9986">rabbit</span>
###xml 880 886 <span type="species:ncbi:9986">rabbit</span>
###xml 1032 1038 <span type="species:ncbi:9986">rabbit</span>
Set7/9 may be necessary for maintenance of dimethylated H3 Lys4 at the Ins1/2 and Slc2a2 genes in mouse islets and occupies the Slc2a2 gene in betaTC3 cells. A: Male C57BL/6 mice were injected intraperitoneally with stabilized control siRNA or siRNA against Set7/9 (siSet1) as described in research design and methods. Islets were subsequently harvested and subjected to ChIP using either normal rabbit serum (-Ab) or antibody to dimethylated H3 Lys4 (+Ab). Data are reported as percent recovery of the indicated gene promoter relative to input. Data represent the average of three independent ChIP experiments from mice injected on three separate occasions. B: betaTC3 cells were subjected to ChIP analysis using normal rabbit serum (-Ab) or antibody against Set7/9 (Set7/9 Ab). Recovery of the proximal Slc2a2 and Pdx1 promoters are reported as fold recovery relative to normal rabbit serum. Data represent the average of three independent ChIP assays. *Statistically different (P < 0.05) from data of ChIP assays in which normal rabbit serum was used in place of Set7/9 antibody.
###end p 67
###begin p 68
###xml 163 165 160 162 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ab</italic>
###xml 222 225 219 222 <italic xmlns:xlink="http://www.w3.org/1999/xlink">+Ab</italic>
###xml 417 418 414 415 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 460 461 457 458 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 667 668 664 665 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 148 154 <span type="species:ncbi:9986">rabbit</span>
Loss of Set7/9 affects Pol II but not Pdx1 recruitment. betaTC3 cells were transfected with siControl or siSet97 and subjected to ChIP using normal rabbit serum (-Ab) or antibody to RNA polymerase II COOH-terminal domain (+Ab). Recovery of the gene fragments was assessed by real-time PCR. Data are reported as recovery of the indicated genes following ChIP as a percent of the input levels of the genes before ChIP. A: ChIP experiment using antibody to Pdx1. B: ChIP experiment using antibody to RNA polymerase II COOH-terminal domain. Data represent the average of three independent ChIP assays from three independent siRNA transfections. *Statistically different (P < 0.05) from data of siControl transfections.
###end p 68

